The EnPlace is a single use trans-vaginal pelvic floor repair system which enables delivery of a ...

FDA Recall #Z-0556-2022 — Class II — December 13, 2021

Recall #Z-0556-2022 Date: December 13, 2021 Classification: Class II Status: Ongoing

Product Description

The EnPlace is a single use trans-vaginal pelvic floor repair system which enables delivery of a tissue anchor to the ligaments of the vaginal cavity. The anchors are pre-loaded inside the device shaft and are ready for use. A thimble is also supplied, as an accessory for the device, to be used as a guide channel for better handling of the EnPlace. Intended Use / Indications for Use: The EnPlace system is intended for attaching sutures to ligaments of the pelvic floor.

Reason for Recall

Certain lots may not have been packaged wth the Channel Tube Limiter.

Recalling Firm

FEMSelect Ltd — Modi'in, N/A

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Devices

Product Quantity

141 units

Distribution

US Nationwide distribution in the state of Georgia.

Code Information

UDI (01)07290017 08201 1 (10) YYMMDDXX (11)YYMMDD (17)YYMMDD, Lot Numbers: 21072510 and 21072512.

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated

What Should You Do?

Stop using this medical device immediately and consult your healthcare provider. Contact the recalling firm for instructions on return or replacement. If you experienced an adverse event, inform your doctor.

Back to All Device Recalls